Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 May 24 424B5 Prospectus supplement for primary offering
- 25 Mar 24 424B5 Prospectus supplement for primary offering
- 14 Feb 24 424B5 Prospectus supplement for primary offering
- 17 Nov 23 424B5 Prospectus supplement for primary offering
- 15 Nov 23 424B5 Prospectus supplement for primary offering
- 1 Sep 23 424B5 Prospectus supplement for primary offering
- 24 Aug 23 EFFECT Notice of effectiveness
-
14 Aug 23 S-3 Shelf registration
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement of MAIA Biotechnology, Inc. on Form S-3 to be filed on or about August 14, 2023 of our report dated April 8, 2022, on our audit of the financial statements as of December 31, 2021 and for the year then ended. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
August 14, 2023